Atlas Trials

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Clinical trial NCT05726227 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05726227
Sponsor
Novo Nordisk A/S
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Obesity
Start date
2023-07-07
Primary completion
2025-10-15
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.